Intracellular bacterial infection and invariant NKT cells

Yonsei Medical Journal

Volumn 50, Issue 1, 2009, Pages 12-21

  Emoto, Masashi ^a   Emoto, Yoshiko ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Intracellular bacteria; Listeria monocytogenes; Liver; Natural killer 1.1; Natural killer T cell; NKR P1

Indexed keywords

CD161 ANTIGEN; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; THYMUS;

ANIMALS; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; NATURAL KILLER T-CELLS;

EID: 62749177546     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.1.12     Document Type: Review

References (100)

1. Kaufmann SH. Immunity to intracellular bacteria. In: Paul WE, editor. Fundamental Immunology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 2003. p.1229-61.
2. North RJ, Conlan JW. Immunity to Listeria monocytogenes. Chem Immunol 1998;70:1-20.
3. Gregory SH, Wing EJ. Neutrophil-Kupffer-cell interaction in host defenses to systemic infections. Immunol Today 1998;19:507-10.
4. Emoto M, Kaufmann SH. Liver NKT cells: an account of heterogeneity. Trends Immunol 2003;24:364-9.
5. 2-microglobulin and NK1.1 expression. Int Immunol 1995; 7:1729-39.
6. intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur J Immunol 1995;25:3321-5.
7. + natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin. Eur J Immunol 1999;29:650-9.
8. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-6.
9. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci U S A 1998;95:5690-3.
10. Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 1999;190:963-72.
11. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001;413:531-4.
12. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001;7:1052-6.
13. + effector function against intracellular infection. J Exp Med 1996;184:131-9.
14. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 2000;12:1267-74.
15. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A 2000;97:8461-6.
16. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 2001;69:213-20.
17. Exley MA, Bigley NJ, Cheng O, Tahir SM, Smiley ST, Carter QL, et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 2001;69:713-8.
18. Duthie MS, Wleklinski-Lee M, Smith S, Nakayama T, Taniguchi M, Kahn SJ. During Trypanosoma cruzi infection CD1-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect Immun 2002;70:36-48.
19. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J Virol 2002;76:4294-303.
20. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002;8:588-93.
21. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003;4: 1230-7.
22. Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semiinvariant Vα14-Jα281 TCR. J Immunol 2003; 170:1430-4.
23. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003; 33:3322-30.
24. Amprey JL, Im JS, Turco SJ, Murray HW, Illarionov PA, Besra GS, et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 2004;200:895-904.
25. Smiley ST, Lanthier PA, Couper KN, Szaba FM, Boyson JE, Chen W, et al. Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice. J Immunol 2005;174:7904-11.
26. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999;189:1973-80.
27. + cells are early IFN-γ producers but impair resistance to Listeria monocytogenes infection. J Immunol 1994;152:1873-82.
28. -T-cell subset after bacterial infection. Infect Immun 2006;74:5903-13.
29. Szalay G, Ladel CH, Blum C, Brossay L, Kronenberg M, Kaufmann SH. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-β2 and Th1 cytokines and ameliorates listeriosis in mice. J Immunol 1999;162:6955-8.
30. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, et al. Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 2002;46:207-10.
31. Bilenki L, Wang S, Yang J, Fan Y, Joyee AG, Yang X. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J Immunol 2005;175:3197-206.
32. Cornish AL, Keating R, Kyparissoudis K, Smyth MJ, Carbone FR, Godfrey DI. NKT cells are not critical for HSV-1 disease resolution. Immunol Cell Biol 2006;84: 13-9.
33. + T cells upon NKR-P1 cross-linking. J Exp Med 1996;183:2391-6.
34. + T cells. J Exp Med 1997; 186:1957-63.
35. Ryan JC, Seaman WE. Divergent functions of lectin-like receptors on NK cells. Immunol Rev 1997;155:79-89.
36. Carlyle JR, Martin A, Mehra A, Attisano L, Tsui FW, Zúñiga-Pflücker JC. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol 1999;162: 5917-23.
37. Kung SK, Su RC, Shannon J, Miller RG. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol 1999;162:5876-87.
38. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM. Genetically linked C-type lectin-related ligands for the NKR-P1 family of natural killer cell receptors. Nat Immunol 2003;4:801-7.
39. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci U S A 2004;101:3527-32.
40. Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, et al. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 2005;175:7791-5.
41. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000; 191:1895-903.
42. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000;192:741-54.
43. + CD1d-dependent precursor stage. J Exp Med 2002;195:835-44.
44. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002;296:553-5.
45. + T lymphocytes. Eur J Immunol 1997; 27:183-8.
46. Emoto Y, Emoto M, Kaufmann SH. Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12. Infect Immun 1997;65:5003-9.
47. + T cells lose NK1.1 expression upon in vitro activation. J Immunol 1997; 158:5112-9.
48. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998;9:345-53.
49. Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000;30:985-92.
50. Osman Y, Kawamura T, Naito T, Takeda K, van Kaer L, Okumura K, et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 2000; 30:1919-28.
51. Leite-de-Moraes MC, Herbelin A, Gouarin C, Koezuka Y, Schneider E, Dy M. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J Immunol 2000;165:4367-71.
52. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Welsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 2001;194:29-44.
53. Hobbs JA, Cho S, Roberts TJ, Sriram V, Zhang J, Xu M, et al. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J Virol 2001;75:10746-54.
54. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat Immunol 2002;3: 867-74.
55. Kirby AC, Yrlid U, Wick MJ. The innate immune response differs in primary and secondary Salmonella infection. J Immunol 2002;169:4450-9.
56. Motsinger A, Haas DW, Stanic AK, van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002;195:869-79.
57. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, Sidobre S, et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 2003;171:4020-7.
58. Wilson MT, Johansson C, Olivares-Villagómez D, Singh AK, Stanic AK, Wang C, et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 2003;100:10913-8.
59. Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, Ito T, et al. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 2004;16:241-7.
60. Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 2005;35:2100-9.
61. Lin Y, Roberts TJ, Wang CR, Cho S, Brutkiewicz RR. Long-term loss of canonical NKT cells following an acute virus infection. Eur J Immunol 2005;35:879-89.
62. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-46.
63. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-γ. J Immunol 1994;152:1883-7.
64. Emoto M, Yoshizawa I, Emoto Y, Takahashi Y, Hurwitz R, Miamoto M, et al. Reversible NK1.1 surface expression by invariant liver natural killer T cells during Listeria monocytogenes infection. Microbes Infect 2007;9:1511-20.
65. Emoto Y, Yoshizawa I, Hurwitz R, Brinkmann V, Kaufmann SH, Emoto M. Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes. Microbes Infect 2008;10:224-32.
66. Oppmann, B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
67. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 1999;162:6410-9.
68. + T cells upon antigen expression in the thymus or in the liver. Eur J Immunol 1999;29:2330-43.
69. Hammond KJ, Pelikan SB, Crowe NY, Randle-Barrett E, Nakayama T, Taniguchi M, et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999; 29:3768-81.
70. +NKT cells. Eur J Immunol 2000;30:2300-11.
71. Coles MC, McMahon CW, Takizawa H, Raulet DH. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol 2000;30:236-44.
72. -cells. J Exp Med 1994;179:1957-72.
73. + T cell development in CD3γ-deficient mice. J Exp Med 1995;182:891-5.
74. + thymocytes. Eur J Immunol 1996;26: 1424-9.
75. Emoto M, Miyamoto M, Emoto Y, Zerrahn J, Kaufmann SH. A critical role of T-cell receptor γ/δ cells in antibacterial protection in mice early in life. Hepatology 2001;33:887-93.
76. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, Ceredig R, et al. Homeostasis of Vα14i NKT cells. Nat Immunol 2002;3:966-74.
77. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, et al. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci U S A 2003;100:2663-8.
78. + cell development. J Immunol 1997;159: 5931-5.
79. + T cells by CD1-expressing cortical thymocytes. J Exp Med 1995; 182:2091-6.
80. + T cells. Int Immunol 1998; 10:1491-9.
81. + natural killer-T cell development. Eur J Immunol 1999;29:3313-8.
82. + natural killer T cells in the liver is maintained without supply by the thymus during adult life. Immunology 2001;104:135-41.
83. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-62.
84. Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, et al. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J Immunol 1997; 158:5603-11.
85. Hameg A, Apostolou I, Leite-De-Moraes M, Gombert JM, Garcia C, Koezuka Y, et al. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen. J Immunol 2000;165:4917-26.
86. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2000;164:4458-64.
87. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002;195:625-36.
88. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 2002;195:637-41.
89. Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, et al. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A 2003;100:8395-400.
90. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003;198:1069-76.
91. Plougastel B, Matsumoto K, Dubbelde C, Yokoyama WM. Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 2001;53:592-8.
92. Holmberg LA, Ault KA. Characterization of Listeria monocytogenes-induced murine natural killer cells. Immunol Res 1986; 5:50-60.
93. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 1991; 124:5-24.
94. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1742-5.
95. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN γ. Immunity 1995; 3:109-17.
96. Iizawa Y, Czuprynski C. Effects of administration of murine recombinant IL-4 on the resistance of mice to Listeria monocytogenes infection. Immunol Lett 1992;32: 185-9.
97. Haak-Frendscho M, Brown JF, Iizawa Y, Wagner RD, Czuprynski CJ. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 1992;148: 3978-85.
98. Szalay G, Ladel CH, Blum C, Kaufmann SH. IL-4 neutralization or TNF-γ treatment ameliorate disease by an intracellular pathogen in IFN-γ receptor-deficient mice. J Immunol 1996;157:4746-50.
99. Kaufmann SH, Emoto M, Szalay G, Barsig J, Flesch IE. Interleukin-4 and listeriosis. Immunol Rev 1997;158: 95-105.
100. + NKT cells participate in the early response to enteric Listeria monocytogenes infection. J Immunol 2005;175:1137-44.